Vor Biopharma (VOR) Common Stock Issued (2020 - 2026)
Vor Biopharma's Common Stock Issued came in at $48.4 million for Q3 2026, up 138.9% from $20.26 million a year earlier.
Powered by 
Analysis
Vor Biopharma (VOR) Common Stock Issued (2020 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Vor Biopharma reported Common Stock Issued of $323.25 million, up 28.9% year-over-year; for FY2025, it was $395.11 million, up 607.8% from FY2024.
- Common Stock Issued carries a five-year compound annual growth rate of 333.2% (FY2020 to FY2025).
- Going back by year, Common Stock Issued was $55.83 million in FY2024, $4.58 million in FY2023 (+2.9%), $4.45 million in FY2022 (-97.6%) and $189.2 million in FY2021.
- The five-year range for quarterly Common Stock Issued is -$246,000 (Q4 2021) to $199.85 million (Q4 2025).
- The fastest year-over-year change in Common Stock Issued over five years came in Q4 2025 (growth of 259.9%), and the weakest in Q2 2026 (a decline of 100.0%).
- Business Quant data shows VOR's Common Stock Issued at $3,000 (Q2 2026), $75 million (Q1 2026) and $199.85 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 743.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 247.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 87.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Vor Biopharma | 1.20 Bn | -692.85 Mn | - | 48.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 48.40 Mn |
| Jun 30, 2026 | 3,000.00 |
| Mar 31, 2026 | 75.00 Mn |
| Dec 31, 2025 | 199.85 Mn |
| Sep 30, 2025 | 20.26 Mn |
| Jun 30, 2025 | 175.00 Mn |
| Dec 31, 2024 | 55.53 Mn |
| Sep 30, 2024 | 111,000.00 |
| Jun 30, 2024 | -92,000.00 |
| Mar 31, 2024 | 278,000.00 |
| Dec 31, 2023 | -15,000.00 |
| Sep 30, 2023 | 392,000.00 |
| Jun 30, 2023 | 565,000.00 |
| Mar 31, 2023 | 3.64 Mn |
| Dec 31, 2022 | 106,000.00 |
| Sep 30, 2022 | 3.84 Mn |
| Jun 30, 2022 | 304,000.00 |
| Mar 31, 2022 | 200,000.00 |
| Dec 31, 2021 | -246,000.00 |
| Sep 30, 2021 | 201,000.00 |
API Access
Vor Biopharma Common Stock Issued API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-stock-issued&ticker=VOR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-stock-issued", "ticker": "VOR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-stock-issued&ticker=VOR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();